BACKGROUND: TNFR1/TNFR2 signaling may mediate different cellular and molecular responses (injury versus protection) and the balance may be affected by sex hormones. Previous studies have shown that females have improved myocardial functional recovery, TNFR1 signaling resistance, and increased SOCS3 expression after acute ischemia/reperfusion when compared with males. However, it is unknown whether the TNFR2 pathway protects the myocardium from ischemia/reperfusion injury, and if so, whether sex differences exist in TNFR2-mediated cardioprotection. Therefore, we hypothesized that (1) TNFR2 mediates myocardial protection from ischemia/reperfusion through STAT3, SOCS3, and vascular endothelial growth factor in both sexes; and (2) TNFR2 elicits greater protective signaling in females compared with males. METHODS AND RESULTS: Isolated male and female mouse hearts from TNFR2 knockout, TNFR1/2 knockout, and wild-type (C57BL/6J or B6129SF2/J; n=5 to 6/group) were subjected to 20 minutes ischemia followed by 60 minutes reperfusion. TNFR2 deficiency decreased postischemic myocardial recovery in both sexes but had a greater effect on females. The deleterious effects of TNFR2 ablation were associated with a decrease in mRNA and protein levels of SOCS3, STAT3, and vascular endothelial growth factor as well as an increase in myocardial interleukin-1-beta production in female hearts. However, a significant increase in JNK activation and interleukin-1-beta protein levels was noted in male TNFR2KO hearts after ischemia/reperfusion. Additionally, TNFR1/2 knockout decreased myocardial function in female hearts but not males. This observation was associated with a decrease in mRNA levels of SOCS3, STAT3, and vascular endothelial growth factor and an increase in myocardial p38 mitogen-activated protein kinase activation in females. CONCLUSIONS: Sex differences in the mechanisms of TNFR2-mediated cardioprotection occur by increasing STAT3, SOCS3, and vascular endothelial growth factor in females and by decreasing JNK in males.
BACKGROUND:TNFR1/TNFR2 signaling may mediate different cellular and molecular responses (injury versus protection) and the balance may be affected by sex hormones. Previous studies have shown that females have improved myocardial functional recovery, TNFR1 signaling resistance, and increased SOCS3 expression after acute ischemia/reperfusion when compared with males. However, it is unknown whether the TNFR2 pathway protects the myocardium from ischemia/reperfusion injury, and if so, whether sex differences exist in TNFR2-mediated cardioprotection. Therefore, we hypothesized that (1) TNFR2 mediates myocardial protection from ischemia/reperfusion through STAT3, SOCS3, and vascular endothelial growth factor in both sexes; and (2) TNFR2 elicits greater protective signaling in females compared with males. METHODS AND RESULTS: Isolated male and female mouse hearts from TNFR2 knockout, TNFR1/2 knockout, and wild-type (C57BL/6J or B6129SF2/J; n=5 to 6/group) were subjected to 20 minutes ischemia followed by 60 minutes reperfusion. TNFR2 deficiency decreased postischemic myocardial recovery in both sexes but had a greater effect on females. The deleterious effects of TNFR2 ablation were associated with a decrease in mRNA and protein levels of SOCS3, STAT3, and vascular endothelial growth factor as well as an increase in myocardial interleukin-1-beta production in female hearts. However, a significant increase in JNK activation and interleukin-1-beta protein levels was noted in male TNFR2KO hearts after ischemia/reperfusion. Additionally, TNFR1/2 knockout decreased myocardial function in female hearts but not males. This observation was associated with a decrease in mRNA levels of SOCS3, STAT3, and vascular endothelial growth factor and an increase in myocardial p38 mitogen-activated protein kinase activation in females. CONCLUSIONS: Sex differences in the mechanisms of TNFR2-mediated cardioprotection occur by increasing STAT3, SOCS3, and vascular endothelial growth factor in females and by decreasing JNK in males.
Authors: Meijing Wang; Lauren Baker; Ben M Tsai; Kirstan K Meldrum; Daniel R Meldrum Journal: Am J Physiol Endocrinol Metab Date: 2004-09-14 Impact factor: 4.310
Authors: John S Ikonomidis; John R Barbour; Zainab Amani; Robert E Stroud; Amanda R Herron; David M McClister; Sarah E Camens; Merry L Lindsey; Rupak Mukherjee; Francis G Spinale Journal: Circulation Date: 2005-08-30 Impact factor: 29.690
Authors: K M Kurrelmeyer; L H Michael; G Baumgarten; G E Taffet; J J Peschon; N Sivasubramanian; M L Entman; D L Mann Journal: Proc Natl Acad Sci U S A Date: 2000-05-09 Impact factor: 11.205
Authors: László Szalay; Tomoharu Shimizu; Takao Suzuki; Huang-Ping Yu; Mashkoor A Choudhry; Martin G Schwacha; Loring W Rue; Kirby I Bland; Irshad H Chaudry Journal: Am J Physiol Regul Integr Comp Physiol Date: 2005-10-27 Impact factor: 3.619
Authors: M W Irwin; S Mak; D L Mann; R Qu; J M Penninger; A Yan; F Dawood; W H Wen; Z Shou; P Liu Journal: Circulation Date: 1999-03-23 Impact factor: 29.690
Authors: N G Frangogiannis; M L Lindsey; L H Michael; K A Youker; R B Bressler; L H Mendoza; R N Spengler; C W Smith; M L Entman Journal: Circulation Date: 1998-08-18 Impact factor: 29.690
Authors: Rama Surya Prakash Perepu; David E Dostal; Carlos Garcia; Richard H Kennedy; Rajat Sethi Journal: Mol Cell Biochem Date: 2011-09-27 Impact factor: 3.396
Authors: Andreas Koenig; Adam Sateriale; Ralph C Budd; Sally A Huber; Iwona A Buskiewicz Journal: J Cardiovasc Transl Res Date: 2013-12-10 Impact factor: 4.132
Authors: Marlo Möller; Friederike Flachsbart; Andreas Till; Thorsten Thye; Rolf D Horstmann; Christian G Meyer; Ivy Osei; Paul D van Helden; Eileen G Hoal; Stefan Schreiber; Almut Nebel; Andre Franke Journal: Am J Respir Crit Care Med Date: 2009-12-10 Impact factor: 21.405
Authors: Megan L Kelly; Meijing Wang; Paul R Crisostomo; Aaron M Abarbanell; Jeremy L Herrmann; Brent R Weil; Daniel R Meldrum Journal: Shock Date: 2010-06 Impact factor: 3.454
Authors: Jana S Burchfield; Jian-Wen Dong; Yasushi Sakata; Feng Gao; Huei-Ping Tzeng; Veli K Topkara; Mark L Entman; Natarajan Sivasubramanian; Douglas L Mann Journal: Circ Heart Fail Date: 2009-10-30 Impact factor: 8.790
Authors: R S Al-Lamki; A P Brookes; J Wang; M J Reid; J Parameshwar; M J Goddard; G Tellides; T Wan; W Min; J S Pober; J R Bradley Journal: Am J Transplant Date: 2009-09-25 Impact factor: 8.086